文献速递乳腺癌

激素受体阳性乳腺癌术后母乳喂养:POSITIVE试验结果

Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial.
PubMed 文献 · J Clin Oncol · 2025-07-09

POSITIVE是一项前瞻性试验,在早期激素受体阳性乳腺癌中断内分泌治疗以尝试妊娠的女性中,未观察到短期乳腺癌事件风险增加。本分析描述母乳喂养的频率、时长和侧别,并按母乳喂养状态估计乳腺癌事件的累积发生率。

要点

  • 313例可分析患者中196例(62.6%)进行母乳喂养。
  • 保乳手术者130/167例(77.8%)母乳喂养,其中90/130例(69.2%)仅从健侧乳房喂养。
  • 中位随访41个月,母乳喂养组与非母乳喂养组24个月乳腺癌事件累积发生率分别为3.6%与3.1%,差异0.5%(95%CI -4.3%至5.2%)。

核心结论

  • 在POSITIVE试验中,乳腺癌诊断后分娩的女性有三分之二进行了母乳喂养,多数持续4个月或更久。
  • 早期随访中,母乳喂养女性与未母乳喂养女性的乳腺癌相关事件未见差异。

研究设计与样本

  • POSITIVE是一项前瞻性试验,入组早期激素受体阳性乳腺癌中断内分泌治疗以尝试妊娠的女性。
  • 本分析纳入317例至少有一次活产的患者中的313例符合分析条件者,中位随访41个月。

主要发现

  • 313例中196例(62.6%)母乳喂养。
  • 保乳手术者167例中130例(77.8%)母乳喂养,其中130例中90例(69.2%)仅从健侧乳房喂养。
  • 单侧乳房切除术者146例中66例(45.2%)母乳喂养。
  • 年龄大于35岁者母乳喂养频率为67.6%,无既往子女者为66.4%。
  • 196例母乳喂养者中103例(52.6%)首次活产后母乳喂养超过4个月,中位4.4个月(95%CI 4.0至5.3)。

关键数值与推荐

  • 首次研究内活产后24个月乳腺癌事件累积发生率:母乳喂养组3.6%,非母乳喂养组3.1%,差异0.5%(95%CI -4.3%至5.2%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We investigated breastfeeding patterns, behaviors, and association with breast cancer (BC) outcomes in women with early hormone receptor-positive (HR+) BC who had a live birth in the POSITIVE trial. PATIENTS AND METHODS: POSITIVE is a prospective trial that demonstrated no increased short-term risk of BC events in women with early HR+ BC who interrupted endocrine therapy (ET) to attempt pregnancy. We describe the frequency, duration, and laterality of breastfeeding and estimate the cumulative incidence of BC events by breastfeeding status. RESULTS: At a median follow-up of 41 months, 317 patients had at least one live birth and 313 were eligible for this analysis. A total of 196 of 313 (62.6%) patients breastfed. A total of 130 of the 167 women (77.8%) who had breast-conserving surgery breastfed, and 90 of 130 (69.2%) breastfed from the unaffected breast only. Sixty-six of the 146 women (45.2%) who underwent unilateral mastectomy breastfed. The frequency of breastfeeding was higher in women older than 35 years (67.6% v 55.7%) and in those without previous children (66.4% v 48.5%). Over half (103 of 196, 52.6%) of women breastfed their first live birth for >4 months (median 4.4 months; 95% CI, 4.0 to 5.3). The cumulative incidence of a BC event at 24 months from first on-study live birth was 3.6% and 3.1% in the breastfeeding and nonbreastfeeding groups, respectively (0.5% difference; 95% CI, -4.3% to 5.2%). CONCLUSION: In POSITIVE, two thirds of women who gave birth after BC diagnosis breastfed, mostly for 4 months or more. In early follow-up, we did not observe differences in BC-related events in women who breastfed compared with those who did not. These results are key for women who wish to pursue pregnancy and breastfeeding after BC.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Peccatori FA, Niman SM, Partridge AH, et al. Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial. J Clin Oncol. 2025. PMID: 40632989. doi:10.1200/JCO-24-02697

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。